Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

XOMA Royalty (XOMA) Operating Expenses (2016 - 2025)

XOMA Royalty (XOMA) has disclosed Operating Expenses for 10 consecutive years, with $11.6 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 27.51% to $11.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.8 million through Dec 2025, down 40.46% year-over-year, with the annual reading at $40.8 million for FY2025, 40.46% down from the prior year.
  • Operating Expenses hit $11.6 million in Q4 2025 for XOMA Royalty, up from $10.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $22.8 million in Q3 2024 to a low of $4.0 million in Q2 2021.
  • Historically, Operating Expenses has averaged $10.0 million across 5 years, with a median of $8.1 million in 2022.
  • Biggest five-year swings in Operating Expenses: surged 245.13% in 2024 and later tumbled 59.72% in 2025.
  • Year by year, Operating Expenses stood at $5.6 million in 2021, then skyrocketed by 37.92% to $7.7 million in 2022, then skyrocketed by 182.84% to $21.8 million in 2023, then dropped by 26.65% to $16.0 million in 2024, then decreased by 27.51% to $11.6 million in 2025.
  • Business Quant data shows Operating Expenses for XOMA at $11.6 million in Q4 2025, $10.7 million in Q3 2025, and $8.5 million in Q2 2025.